A high triglyceride to high-density lipoprotein cholesterol ratio is associated with poor renal outcome in IgA nephropathy patients
暂无分享,去创建一个
Xiaoping Zhou | D. Yang | Lingqiu Dong | Jiaxing Tan | Siqing Wang | A. Qin | Yi Tang | W. Qin | G. Pei | Xiang Liu
[1] P. López-Jaramillo,et al. Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary , 2021, Hypertension.
[2] Xiaoqiang Ding,et al. The effect of triglycerides to high-density lipoprotein cholesterol ratio on the reduction of renal function: findings from China health and retirement longitudinal study (CHARLS) , 2021, Lipids in Health and Disease.
[3] Lingqiu Dong,et al. High Neutrophil-To-Lymphocyte Ratio Is an Independent Risk Factor for End Stage Renal Diseases in IgA Nephropathy , 2021, Frontiers in Immunology.
[4] J. J. Lozano-Nuevo,et al. High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients , 2021, Clinical Nutrition ESPEN.
[5] S. Bakker,et al. The triglyceride to HDL-cholesterol ratio and chronic graft failure in renal transplantation. , 2021, Journal of clinical lipidology.
[6] Y. Kim,et al. Predictive value of triglyceride/high-density lipoprotein cholesterol for major clinical outcomes in advanced chronic kidney disease: a nationwide population-based study , 2020, Clinical kidney journal.
[7] E. Bonora,et al. Independent association of atherogenic dyslipidaemia with all‐cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study , 2020, Cardiovascular Diabetology.
[8] D. Kyriaki,et al. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Predicts Chronic Renal Disease in Patients without Diabetes Mellitus (STELLA Study) , 2020, Journal of cardiovascular development and disease.
[9] H. Zou,et al. Association of Lipid Parameters with the Risk of Chronic Kidney Disease: A Longitudinal Study Based on Populations in Southern China , 2020, Diabetes, metabolic syndrome and obesity : targets and therapy.
[10] Andrew M. Wilson,et al. Elevated Triglycerides to High-Density Lipoprotein Cholesterol (TG/HDL-C) Ratio Predicts Long-Term Mortality in High-Risk Patients. , 2020, Heart, lung & circulation.
[11] G. Hu,et al. Nonlinear relationship between triglyceride/high-density lipoprotein cholesterol ratio and chronic kidney disease in US adults: a National Health and Nutrition Examination Survey investigation , 2019, International Urology and Nephrology.
[12] Ž. Reiner. Hypertriglyceridaemia and risk of coronary artery disease , 2017, Nature Reviews Cardiology.
[13] L. Juillard,et al. Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins , 2016, Toxins.
[14] Y. Ohashi,et al. Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese Population. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] Y. Weng,et al. Relationship between TG/HDL-C ratio and metabolic syndrome risk factors with chronic kidney disease in healthy adult population. , 2015, Clinical nutrition.
[16] S. Devaraj,et al. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. , 2014, The Journal of clinical endocrinology and metabolism.
[17] C. Schmid,et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. , 2011, Kidney international.
[18] C. Cohen,et al. Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. , 2010, American journal of physiology. Renal physiology.
[19] N. Vaziri. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. , 2006, American journal of physiology. Renal physiology.
[20] P. Zucchelli,et al. [IgA nephropathy]. , 1985, Medicina clinica.